Vulvovaginal Candidiasis
Reproductive·MeSH: Candidiasis
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| brexafemme | SCYNEXIS INC (SCYX) |
Phase 3(1)
| Drug | Company |
|---|---|
| ibrexafungerp | SCYNEXIS INC (SCYX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Vulvovaginal Candidiasis?
BioSniper tracks 2 drugs in development for Vulvovaginal Candidiasis across 1 company.
How many clinical trials target Vulvovaginal Candidiasis?
There are 1 clinical trial targeting Vulvovaginal Candidiasis tracked by BioSniper.
Deep-dive into Vulvovaginal Candidiasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis